Skip to main content
. 2021 Aug 4;23(8):527–536. doi: 10.1089/dia.2020.0675

FIG. 1.

FIG. 1.

Data are shown for the cohort of 1311 patients with 3 years of follow-up data post-tubeless insulin pump initiation. Comparison of the estimated mean ± SEM of DKA (top panel) and SH (Level 3) (bottom panel) adjusted for age, diabetes duration, gender, baseline-HbA1c with either MDI (n = 1874) or tubeless pump (n = 1311) treated at the same centers during the same 3-year time period. For the MDI group, the “Year Prior” corresponds to the third year before last year evaluated. DKA, diabetic ketoacidosis; HbA1c, hemoglobin A1c; MDI, multiple daily injection.